Second Line Capital’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Buy
2,415
+118
+5% +$13.3K 0.04% 168
2025
Q4
$288K Buy
2,297
+26
+1% +$3.31K 0.06% 115
2025
Q3
$304K Sell
2,271
-317
-12% -$41.6K 0.06% 112
2025
Q2
$352K Buy
2,588
+1
+0% +$132 0.08% 94
2025
Q1
$343K Buy
2,587
+775
+43% +$98.6K 0.09% 90
2024
Q4
$205K Sell
1,812
-629
-26% -$72.7K 0.06% 123
2024
Q3
$278K Buy
+2,441
New +$268K 0.08% 95

Other funds holding ABT

Second Line Capital's ABT Position: Q1 2026 in Review

Second Line Capital increased its Abbott (ABT) stake by 5.1% in Q1 2026, buying an estimated $13.3K and bringing the position to 2,415 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #168.

Second Line Capital first reported a position in ABT in Q3 2024 and has held it in 7 quarters since. The position peaked at $352K in Q2 2025. 3,084 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Second Line Capital held 2,415 shares of Abbott worth $219K as of Q1 2026.
  • Second Line Capital bought 118 Abbott shares in Q1 2026, an estimated $13.3K.
  • Abbott made up 0.04% of Second Line Capital's portfolio in Q1 2026, its #168 holding.
  • Second Line Capital first reported a position in Abbott in Q3 2024 and has held it in 7 quarters since.
  • Second Line Capital's Abbott position peaked at $352K in Q2 2025.
  • 3,084 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Second Line Capital's 13F filing for Q1 2026, filed 15 May 2026.